文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于引发靶向多个表位的抗体的HIV-1候选疫苗的设计与特性分析

Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.

作者信息

Gristick Harry B, Hartweger Harald, Nishimura Yoshiaki, Gavor Edem, Nagashima Kaito, Koranda Nicholas S, Gnanapragasam Priyanthi N P, Kakutani Leesa M, Segovia Luisa N, Donau Olivia K, Keeffe Jennifer R, West Anthony P, Martin Malcolm A, Nussenzweig Michel C, Bjorkman Pamela J

机构信息

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.

Laboratory of Molecular Immunology, The Rockefeller University , New York, NY, USA.

出版信息

J Exp Med. 2025 Oct 6;222(10). doi: 10.1084/jem.20250693. Epub 2025 Aug 12.


DOI:10.1084/jem.20250693
PMID:40794027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12341506/
Abstract

A primary goal in the development of an AIDS vaccine is the elicitation of broadly neutralizing antibodies (bNAbs) that protect against diverse HIV-1 strains. To this aim, germline-targeting immunogens have been developed to activate bNAb precursors and initiate the induction of bNAbs. While most preclinical germline-targeting HIV-1 vaccine candidates only include a single bNAb precursor epitope, an effective HIV-1 vaccine will likely require bNAbs that target multiple epitopes on Env. Here, we report a newly designed germline-targeting Env SOSIP trimer, named 3nv.2, that presents three bNAb epitopes on Env: the CD4bs, V3, and V2 epitopes. 3nv.2 forms a stable trimeric Env and binds to bNAb precursors from each of the desired epitopes. Immunization experiments in rhesus macaques and mice demonstrate 3nv.2 elicits the combined effects of its parent immunogens. Our results provide proof of concept for using a germline-targeting immunogen presenting three or more bNAb epitopes and a framework to develop improved next-generation HIV-1 vaccine candidates.

摘要

开发艾滋病疫苗的一个主要目标是诱导产生能抵御多种HIV-1毒株的广泛中和抗体(bNAb)。为实现这一目标,已开发出靶向胚系的免疫原,以激活bNAb前体并启动bNAb的诱导。虽然大多数临床前靶向胚系的HIV-1疫苗候选物仅包含单个bNAb前体表位,但有效的HIV-1疫苗可能需要能靶向Env上多个表位的bNAb。在此,我们报告一种新设计的靶向胚系的Env SOSIP三聚体,名为3nv.2,它在Env上呈现三个bNAb表位:CD4结合位点(CD4bs)、V3和V2表位。3nv.2形成稳定的三聚体Env,并与来自每个所需表位的bNAb前体结合。在恒河猴和小鼠身上进行的免疫实验表明,3nv.2引发了其亲本免疫原的联合效应。我们的结果为使用呈现三个或更多bNAb表位的靶向胚系免疫原提供了概念验证,并为开发改进的下一代HIV-1疫苗候选物提供了一个框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/d5cfb36596f6/jem_20250693_figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/060f6475dffc/jem_20250693_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/91dcb3c68b3b/jem_20250693_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/694e40c3b36f/jem_20250693_figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/7d7336f5167e/jem_20250693_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/64c18f3c2693/jem_20250693_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/d5cfb36596f6/jem_20250693_figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/060f6475dffc/jem_20250693_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/91dcb3c68b3b/jem_20250693_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/694e40c3b36f/jem_20250693_figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/7d7336f5167e/jem_20250693_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/64c18f3c2693/jem_20250693_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/12341506/d5cfb36596f6/jem_20250693_figs2.jpg

相似文献

[1]
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.

J Exp Med. 2025-10-6

[2]
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.

bioRxiv. 2025-1-9

[3]
Inducible cell lines producing replication-defective human immunodeficiency virus particles containing envelope glycoproteins stabilized in a pretriggered conformation.

J Virol. 2024-12-17

[4]
Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques.

Sci Immunol. 2024-8-30

[5]
HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates.

Sci Immunol. 2025-8-22

[6]
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer.

Immunity. 2025-6-10

[7]
Anti-immune complex antibodies are elicited during repeated immunization with HIV Env immunogens.

Sci Immunol. 2025-1-17

[8]
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models.

Sci Transl Med. 2025-7-30

[9]
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.

Proc Natl Acad Sci U S A. 2025-8-19

[10]
Germline-targeting HIV Envelope SOSIP immunization more frequently elicits broadly-neutralizing antibody precursor responses in infant compared to juvenile rhesus macaques.

bioRxiv. 2025-5-30

本文引用的文献

[1]
Neutralizing antibodies elicited in macaques recognize V3 residues on altered conformations of HIV-1 Env trimer.

NPJ Vaccines. 2024-12-5

[2]
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques.

Cell. 2024-12-12

[3]
Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals.

Cell. 2024-10-3

[4]
HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.

Nature. 2023-11

[5]
Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping.

STAR Protoc. 2023-9-15

[6]
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller.

Cell Host Microbe. 2023-8-9

[7]
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

PLoS Pathog. 2023-6

[8]
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.

Cell Rep Med. 2023-4-18

[9]
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals.

Sci Immunol. 2023-2-17

[10]
HIV-1 CD4-binding site germline antibody-Env structures inform vaccine design.

Nat Commun. 2022-10-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索